ADMA Biologics Inc (ADMA)

Net profit margin

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net income (ttm)	US$ in thousands	68,132	34,788	-3,645	-28,240	-22,827	-40,292	-47,686	-65,905	-70,322	-73,135	-78,275	-71,647	-74,406	-73,610	-74,883	-75,748	-66,901	-61,422	-54,456	-48,279
Revenue (ttm)	US$ in thousands	382,809	330,245	283,177	258,216	234,293	208,108	181,890	154,079	130,481	110,072	93,998	80,944	68,517	58,112	48,069	42,220	40,301	37,248	36,021	29,350
Net profit margin		17.80%	10.53%	-1.29%	-10.94%	-9.74%	-19.36%	-26.22%	-42.77%	-53.89%	-66.44%	-83.27%	-88.51%	-108.59%	-126.67%	-155.78%	-179.41%	-166.00%	-164.90%	-151.18%	-164.49%

September 30, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $68,132K ÷ $382,809K
= 17.80%

Based on the historical data provided, the net profit margin of ADMA Biologics Inc has shown significant fluctuations over the periods indicated. The net profit margin, which represents the percentage of each dollar of revenue that results in profit after all expenses are deducted, experienced a positive trend in the most recent quarters, with percentages of 17.80% in Sep 30, 2024, and 10.53% in Jun 30, 2024.

Prior to this improvement, the company faced challenges, as reflected by negative net profit margins in earlier quarters, such as -1.29% in Mar 31, 2024, -10.94% in Dec 31, 2023, and -9.74% in Sep 30, 2023. The trend of negative net profit margins extended further back, illustrating significant losses in profitability in periods like -155.78% in Mar 31, 2021, -179.41% in Dec 31, 2020, and -166.00% in Sep 30, 2020.

These wide fluctuations in the net profit margin suggest variability in the company's ability to generate profits from its operations, indicating potential challenges or changes in the business environment. The recent positive trend in net profit margin may indicate improvements in efficiency, cost management, or revenue generation strategies that have positively impacted the company's profitability. However, further monitoring and analysis will be necessary to assess the sustainability of this improvement and the overall financial health of ADMA Biologics Inc.